Brief: Theradiag FY Revenue Up 7% At 11.1 Million Euros

Theradiag SA

31/01/2022 06:37

Jan 31 (Reuters) - Theradiag SA  ALTHE.PA :
    * THERADIAG POSTS 2021 REVENUE OF €11.1 MILLION, UP 7%
    * CASH POSITION AT DECEMBER 31, 2021: EUR 7.1 MILLION
    * FURTHER EXPANSION IN ACTIVITY IN UNITED STATES, WITH
GROWTH OF
17%
    * ADDITIONAL RESOURCES WILL ALLOW THERADIAG TO IMPLEMENT ITS
STRATEGIC PLAN
    * OUTLOOK: SECURE QUALITY AND COMMERCIAL SUPPLY OF
ANTIBODIES VIA
HUMABDIAG PROJECT DEVELOPED THANKS TO RECENT PARTNERSHIP WITH
UNIVERSITY OF TOURS
    * OUTLOOK: ACCELERATE INTERNATIONALIZATION OF EXISTING
ACTIVITIES
IN WORLD'S MAIN HEALTHCARE COUNTRIES, AND IN PARTICULAR
ACCELERATE SALES IN UNITED STATES
    * OUTLOOK: DEVELOP A TECHNOLOGICAL SOLUTION TO ENSURE NEAR
PATIENT
TESTING
    * OUTLOOK: INVEST IN NEW THERAPEUTIC FIELDS WITH SUBSTANTIAL
DEMAND AND STRONG GROWTH
    * OUTLOOK: COMFORTABLE CASH POSITION WITH FINANCING HORIZON
ASSURED UNTIL END-2026

Source text for Eikon:  ID:nBw90sNf7a 
Further company coverage:  ALTHE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))